SWOG clinical trial number
CTSU/NRG-GU005

Phase III IGRT and SBRT Vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer

Open
Abbreviated Title
PIII IGRT and SBRT Vs IGRT and Hypofractionated IMRT
Status Notes
This study is active in SWOG effective October 1, 2019.
Activated
10/01/2019

Research committees

Genitourinary Cancer

Treatment

Radiation Therapy

Eligibility Criteria Expand/Collapse

Please see eligibility criteria in protocol on www.CTSU.org

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/NRG-GU005
SWOG Clinical Trial Number
S1806

Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer.

Research Committee(s)
Genitourinary Cancer
Activated
04/19/2019
Accrual
25%
Open
Phase
III
SWOG Clinical Trial Number
S1802